Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 171
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06518837 | Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer | ||
| NCT00966667 | Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer | ||
| NCT00176462 | CINJALL: Treatment for Children With Acute Lymphocytic Leukemia | ||
| NCT00587886 | Estrogen, Diet, Genetics and Endometrial Cancer | ||
| NCT00323063 | Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer | ||
| NCT04294264 | TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer | ||
| NCT04751747 | Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer | ||
| NCT02400190 | The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) | ||
| NCT00822952 | Prostate Mechanical Imager (PMI) Clinical Bridging Study | ||
| NCT02177838 | Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer | ||
| NCT04141449 | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | ||
| NCT03902379 | Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer | ||
| NCT00866840 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | ||
| NCT00770419 | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers | ||
| NCT00770055 | Internet Use Among Women With Recurrent Metastatic Breast Cancer | ||
| NCT02203578 | Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease | ||
| NCT03725449 | Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma | ||
| NCT02250781 | Oral ONC201 in Treating Patients With Advanced Solid Tumors | ||
| NCT06927700 | Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes | ||
| NCT00138151 | Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | ||
| NCT04253483 | Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer | ||
| NCT01745588 | Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma | ||
| NCT04929015 | Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) | ||
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | ||
| NCT01694589 | A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | ||
| NCT00156299 | Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate | ||
| NCT04445844 | INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study | ||
| NCT00765765 | Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer | ||
| NCT03382158 | International PPB/DICER1 Registry | ||
| NCT00991315 | Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate | ||
| NCT05373823 | MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors | ||
| NCT00905918 | Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer | ||
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | ||
| NCT01794676 | Genetic Evaluation of Families With Endocrine Cancers | ||
| NCT00176475 | Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease | ||
| NCT02421575 | Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | ||
| NCT03257163 | Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer | ||
| NCT02382419 | Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants | ||
| NCT04285268 | Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT00939380 | Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial | ||
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | ||
| NCT00853125 | Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | ||
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | ||
| NCT00786682 | Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer | ||
| NCT06704295 | High Impact E-cigarette Advertisement Features | ||
| NCT00728845 | Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer | ||
| NCT00996359 | Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation | ||
| NCT01652014 | Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies | ||
| NCT04713449 | Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial | ||
| NCT02203604 | High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery |
